Collaborators, Consultants, Advisors
Team
Background:
Led by Jack Oswald, a successful serial entrepreneur who has built several companies from the ground up in a wide variety of technical fields, the management team at ISOThrive has executed crisply in many areas including R&D, intellectual property creation, product production and scale up, and science collaborations.
We have assembled a world class team of professionals in all areas of required competence: management, commercialization, business development, clinical research, bench science, microbiome analytics, and production engineering.
Leadership Team:
Jack Oswald, MBA, CEO/CTO
ISOThrive Co-Founder, CEO and CTO AB Dartmouth, MBA Harvard. Former company was sold to Motorola. One of the inventors of ISOT-101, Jack is a visionary leader providing overall strategy and direction, scientific and engineering expertise.
Mike Walther, Chief Strategy Officer, Member Board of Directors
Industry experience spans greater than 30-years focused on GI pharmaceuticals, medical devices and diagnostics. He launched two of the most widely prescribed proton pump inhibitors (PPIs), Prevacid and Dexilant, for the treatment of gastroesophageal reflux disease (GERD).
Peter Swann, MD, Chief Medical Officer
ISOThrive Co-founder and Chief Medical Officer, Dr. Swann is a subject matter expert in the fields of prebiotics, probiotics and the microbiome. He is a Board Certified Family Physician with a focus on patient health, wellness and prevention.
Lee R. Madsen II, PhD, VP, Chief Science Officer
ISOThrive Co-founder and Chief Science Officer, Dr. Madsen is one of the world’s leading carbohydrate researchers, one of the inventors of ISOT-101, and head of ISOThrive’s R&D laboratory in Manassas, VA.
Lyn Oswald, Chief Operating Officer
ISOThrive Co-founder and Chief Operating Officer. Results-oriented leader with more than 30 years’ experience in operations, marketing, business development and fund raising.
Research Collaborators and Key Advisors:
We have assembled a collaboration of prominent Universities across the U.S., to study ISOT-101.
John Selling, MD
ISOThrive Co-Founder and Medical Advisor is Clinical Associate Professor of Medicine and Gastroenterology, (retired), Lifetime Honorary Stanford Hospital Medical Staff Member, Stanford Medical School. Dr. Selling has 33 years experience in GI physiology research and practice, with published research in NEJM, Annals of Internal Medicine and Gastroenterology.
Michael Vaezi, PhD, MD, MS
Clinical Director, Division of Gastroenterology, Director of the Center for Swallowing and Esophageal Disorders, and Professor of Medicine, Vanderbilt University School of Medicine
Pat Gillevet, PhD
Director of GMU’s Microbiome Analysis Center.
David Johnson, MD
Professor of Medicine and Chief of Gastroenterology (EVMS).
Jeanetta Frye, MD
Assistant Professor (UVA).
John Clarke, MD
Clinical Professor, Medicine - Gastroenterology and Hepatology, Director Esophageal Program (Stanford).
Prakash Gyawali, MD
Professor of Medicine, Director Neurogastroenterology and Motility, Director GI Fellowship Training (Washington University, St. Louis).
Contact Us
Looking for more information about ISOThrive? Submit your email below, and we will reach out to you!